Kaye J. Williams

Anticancer Chemosensitization and Radiosensitization by the Novel Poly(ADP-ribose) Polymerase-1 Inhibitor AG14361

Christopher Calabrese, Robert J. Almassy, Stephen Barton et al. · JNCI Journal of the National Cancer Institute · 2004 · 485 citations · Full text

Medicine, Oncology, Pharmacology +15

Hypoxia-Mediated Down-Regulation of Bid and Bax in Tumors Occurs via Hypoxia-Inducible Factor 1-Dependent and -Independent Mechanisms and Contributes to Drug Resistance

Janine T. Erler, Christopher Cawthorne, Kaye J. Williams et al. · Molecular and Cellular Biology · 2004 · 389 citations · Full text

Medicine, Cancer Biology, Oncology +17

HIF-1 and NF-κB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells

P Maxwell, Ryan S. Gallagher, Angela Seaton et al. · Oncogene · 2007 · 201 citations

Medicine, Cell Biology, Oncology +16

Inhibition of Monocarboxylate Transporter-1 (MCT1) by AZD3965 Enhances Radiosensitivity by Reducing Lactate Transport

Becky M. Bola, Amy L. Chadwick, Filippos Michopoulos et al. · Molecular Cancer Therapeutics · 2014 · 194 citations · Full text

Medicine, Oncology, Pharmacology +17

ZD1839 (‘Iressa’), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft model

Kaye J. Williams, Brian A. Telfer, Ian J. Stratford et al. · British Journal of Cancer · 2002 · 175 citations · Full text

Medicine, Oncology, Pharmacology +15